Leap Therapeutics Inc. (LPTX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for LPTX in the last 30 days. The most recent was published Nov 13, 2025.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Latest news

25 items

LPTX FAQ

7 questions
  • What does Leap Therapeutics Inc. do?
    Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
  • What is the latest news on LPTX?
    Quantisnow has not tracked any new filings, ratings or press releases for LPTX in the last 30 days. The most recent wire item was published on November 13, 2025.
  • Where does LPTX stock trade?
    Leap Therapeutics Inc. (LPTX) is listed on NASDAQ.
  • What sector and industry is LPTX in?
    Leap Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What are analysts saying about LPTX?
    Across the last 5 analyst actions on Leap Therapeutics Inc., there were 0 upgrades and 2 downgrades. The most recent action was from H.C. Wainwright: Neutral on 2025-01-29.
  • What companies are similar to LPTX?
    Notable peers in the same industry include ABT (Abbott Laboratories), JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC). Compare LPTX side-by-side with any of them on Quantisnow.
  • How can I track LPTX on Quantisnow?
    Quantisnow aggregates Leap Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LPTX to receive live email and push alerts on every new disclosure.